VAL

VALIRX PLC ORD 0.1P

TitleTime
Result of General MeetingFri 22/05/20 | 12:04
Group Projects Summary & Board Expansion PlansTue 19/05/20 | 14:00
Second Price Monitoring ExtnThu 07/05/20 | 14:05
Price Monitoring ExtensionThu 07/05/20 | 14:01
Appointment of DirectorThu 07/05/20 | 07:00
Posting of Circular and Notice of General MeetingWed 06/05/20 | 16:23
Holding(s) in CompanyWed 06/05/20 | 09:05
Broker Option - Fully SubscribedMon 04/05/20 | 15:00
Holding(s) in CompanyMon 04/05/20 | 08:27
Holding(s) in CompanyMon 04/05/20 | 08:24
Conditional Fundraise of £1.2 millionMon 04/05/20 | 07:00
Share Price MovementFri 01/05/20 | 13:34
Holding(s) in CompanyFri 01/05/20 | 09:21
Material Transfer AgreementFri 01/05/20 | 08:16
Proposed appointment of DirectorFri 01/05/20 | 07:00
Holding(s) in CompanyThu 30/04/20 | 08:00
Change of Management TeamThu 30/04/20 | 07:00
Statement re social media reportsWed 29/04/20 | 17:42
Holding(s) in CompanyFri 24/04/20 | 07:00
Holding(s) in CompanyThu 23/04/20 | 11:04
Second Price Monitoring ExtnThu 16/04/20 | 14:05
Price Monitoring ExtensionThu 16/04/20 | 14:00
Result of General Meeting & Directorate ChangeTue 14/04/20 | 12:41
Change of DirectorTue 14/04/20 | 10:08
Change of Arrangements for General MeetingThu 09/04/20 | 14:39
Result of General MeetingWed 01/04/20 | 11:59
Conditional PlacingWed 01/04/20 | 07:00
UpdateMon 30/03/20 | 07:00
General Meeting - AdjournmentWed 25/03/20 | 09:44
Posting of Circular & Notice of General MeetingMon 16/03/20 | 07:00
Posting of Circular & Notice of General MeetingTue 10/03/20 | 07:00
Shareholder Requisition NoticeWed 04/03/20 | 15:28
Second Price Monitoring ExtnMon 17/02/20 | 14:05
Price Monitoring ExtensionMon 17/02/20 | 14:00
Result of General Meeting & working capital updateMon 17/02/20 | 12:07
Change of Venue for General Meeting-17 Feb 2020Wed 12/02/20 | 07:00
Posting of Circular & Notice of General MeetingThu 30/01/20 | 14:00
Update - ValiSeekTue 14/01/20 | 07:00
Placing, Issue of Warrant & Appointment of BrokerMon 06/01/20 | 07:00
Second Price Monitoring ExtnMon 16/12/19 | 09:05
Price Monitoring ExtensionMon 16/12/19 | 09:00
VAL201 UpdateMon 16/12/19 | 07:00
US Patent Grant re VAL201 & Metastatic CancerThu 28/11/19 | 07:00
Holding(s) in CompanyWed 13/11/19 | 11:33
Appointment of Joint BrokerWed 13/11/19 | 07:00
Holding(s) in CompanyMon 11/11/19 | 15:30
Passing of Non-Executive ChairmanMon 21/10/19 | 11:47
Placing & Issue of EquityMon 14/10/19 | 13:23
Price Monitoring ExtensionWed 09/10/19 | 16:35
Half-year ReportThu 26/09/19 | 07:00
Company UpdateTue 24/09/19 | 07:00
Holding(s) in CompanyTue 10/09/19 | 17:15
VAL201 UpdateTue 10/09/19 | 07:00
Company Update & Change of AdviserTue 06/08/19 | 07:00
New European patent allowance for VAL301Thu 01/08/19 | 07:00
Holding(s) in CompanyTue 23/07/19 | 16:02
Appointment of Joint BrokerTue 23/07/19 | 07:00
Change of Registered AddressTue 09/07/19 | 11:14
Update re VAL301Thu 04/07/19 | 07:00
Holding(s) in CompanyFri 28/06/19 | 13:33
Issue of EquityFri 28/06/19 | 12:31
Result of AGMFri 28/06/19 | 12:03
Holding(s) in CompanyWed 26/06/19 | 12:00
US Notice of Allowance-VAL201 & Metastatic CancerWed 26/06/19 | 07:00
Further re: Termination of Subscription AgreementTue 25/06/19 | 14:50
Holding(s) in CompanyMon 24/06/19 | 12:45
Holding(s) in CompanyFri 21/06/19 | 12:00
Update on VAL201 Clinical TrialThu 20/06/19 | 07:00
Holding(s) in CompanyWed 19/06/19 | 12:00
Placing, Subscription Agreement & Issue of WarrantThu 13/06/19 | 07:00
Subscription Agreement UpdateMon 10/06/19 | 07:00
Notice of AGM & Update of Subscription AgreementWed 05/06/19 | 07:00
Subscription Agreement UpdateFri 31/05/19 | 11:07
Holding(s) in CompanyFri 31/05/19 | 10:42
Holding(s) in CompanyThu 30/05/19 | 10:30
Holding(s) in CompanyWed 29/05/19 | 11:44
Final ResultsWed 29/05/19 | 07:00
Subscription Agreement UpdateTue 28/05/19 | 07:00
Holding(s) in CompanyThu 23/05/19 | 12:02
Subscription Agreement UpdateWed 22/05/19 | 07:00
Price Monitoring ExtensionMon 13/05/19 | 14:00
Acquisition of Intellectual Property& JV AgreementThu 02/05/19 | 07:00
Second Price Monitoring ExtnMon 29/04/19 | 14:06
Price Monitoring ExtensionMon 29/04/19 | 14:01
Second Price Monitoring ExtnMon 29/04/19 | 11:07
Price Monitoring ExtensionMon 29/04/19 | 11:01
Holding(s) in CompanyMon 29/04/19 | 10:55
Subscription, Convertible Funds and Warrant IssueFri 26/04/19 | 07:00
ValiSeek UpdateTue 26/03/19 | 07:00
Update on VAL201 & VAL301 Development ProgressThu 21/03/19 | 07:00
Placing, Issue of Equity and WarrantThu 21/02/19 | 11:22
New patent grant allowances for VAL301Thu 31/01/19 | 07:00
Holding(s) in CompanyThu 03/01/19 | 07:00
Second Price Monitoring ExtnTue 18/12/18 | 16:41
Price Monitoring ExtensionTue 18/12/18 | 16:36
Issue of Equity / PDMR ShareholdingsTue 18/12/18 | 11:25
Update on VAL401 - Peer-review AcceptanceTue 18/12/18 | 07:00
Update on VAL201 Clinical TrialMon 10/12/18 | 07:00
VAL201 in concluding stages of Phase I/II trialWed 17/10/18 | 07:00
VAL401 results shortly to be on ClinicalTrials.govMon 15/10/18 | 12:00
Half-year ReportTue 25/09/18 | 07:00
Issue of EquityFri 14/09/18 | 12:42
Update on Clinical DevelopmentThu 06/09/18 | 07:00
Result of General MeetingTue 24/07/18 | 12:17
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301Tue 17/07/18 | 07:00
Notice of GMFri 06/07/18 | 16:42
VAL401 UpdateThu 14/06/18 | 07:00
Price Monitoring ExtensionThu 24/05/18 | 09:00
Holding(s) in CompanyFri 11/05/18 | 14:56
Result of AGMTue 08/05/18 | 12:13
Second Price Monitoring ExtnFri 04/05/18 | 16:40
Price Monitoring ExtensionFri 04/05/18 | 16:35
Placing and grant of warrantsFri 04/05/18 | 16:01
Second Price Monitoring ExtnThu 26/04/18 | 14:05
Price Monitoring ExtensionThu 26/04/18 | 14:00
Second Price Monitoring ExtnWed 25/04/18 | 16:40
Price Monitoring ExtensionWed 25/04/18 | 16:35
EU Patent Grant for Therapeutic Compound, VAL201Wed 25/04/18 | 07:00
GENEICE & VAL101 UpdateThu 19/04/18 | 07:00
Notice of AGMThu 12/04/18 | 07:00
Final ResultsTue 10/04/18 | 07:00
US Patent Grant for Therapeutic Compound, VAL201Tue 20/03/18 | 07:00
Holding(s) in CompanyMon 19/03/18 | 07:00
Appointment of BrokerFri 16/03/18 | 15:01
Statement re brokerFri 02/03/18 | 11:01
Issue of options and directors dealingsFri 09/02/18 | 11:57
Holding(s) in CompanyFri 02/02/18 | 16:26
Holding(s) in CompanyThu 25/01/18 | 12:06
Holding(s) in CompanyTue 23/01/18 | 15:30
ValiSeek Clinical Update (VAL401)Tue 16/01/18 | 07:00
US Patent Notice of Allowance for Compound VAL201Thu 11/01/18 | 07:00
Holding(s) in CompanyThu 04/01/18 | 14:29
Exercise of Warrants and Issue of EquityWed 03/01/18 | 07:00
Final Loan Note Conversion and Issue of EquityWed 27/12/17 | 12:54
Issue of EquityFri 22/12/17 | 07:00
Result of General MeetingThu 21/12/17 | 09:16
Warrant ExerciseWed 20/12/17 | 15:58
Warrant ExerciseWed 20/12/17 | 15:03
Warrant ExerciseMon 18/12/17 | 08:45
re: VAL201 Clinical TrialsMon 18/12/17 | 07:00
Exercise of Warrants and Issue of EquityFri 15/12/17 | 07:00
ValiSeek Clinical Development UpdateTue 12/12/17 | 07:00
Loan Note Conversion and Issue of EquityMon 11/12/17 | 15:48
Shareholder Circular and Notice of General MeetingWed 06/12/17 | 07:00
Issue of EquityThu 30/11/17 | 14:38
Holding(s) in CompanyMon 20/11/17 | 11:23
Yorkville CLN ConversionWed 15/11/17 | 16:37
Notification of US Patent AllowanceWed 11/10/17 | 07:00
Holding(s) in CompanyThu 05/10/17 | 07:00
Total Voting RightsMon 02/10/17 | 07:00
ValiSeek Clinical Development UpdateThu 28/09/17 | 07:00
Holding(s) in CompanyWed 27/09/17 | 15:32
Half-year ReportTue 26/09/17 | 07:00
VAL201 updateWed 20/09/17 | 15:18
Issue of EquityTue 19/09/17 | 07:00
GeneICE & VAL101 UpdateThu 07/09/17 | 07:00
Convertible Loan FacilityFri 11/08/17 | 07:00
Conversion of Loan NoteWed 02/08/17 | 07:00
Licencing AgreementFri 28/07/17 | 07:00
ValiSeek Development Update - Recruitment ClosesThu 15/06/17 | 07:00